ImmunityBio (NASDAQ: IBRX) recently announced a partnership with Accord Healthcare to expand European access to ANKTIVA for bladder cancer patients across 33 countries. ANKTIVA achieved a 71% complete ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit highlights the latest advances in precision medicine ...
Casey Means is an ally of Health and Human Services Secretary Robert F. Kennedy Jr. and an advocate for his "Make America ...
Emerging modalities such as self-amplifying and circular RNA, expanding oncology and rare-disease applications, and scalable manufacturing are creating high-growth investment avenues, supported by ...
Integrating AI with advanced robotics to create self-driving labs (SDL) is a promising approach to tackling molecular discovery. A new SDL system, called LUMI-lab, combines large-scale molecular ...
ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.
Novartis has announced plans to establish a 46,000-square-foot radioligand therapy manufacturing facility in Denton, Texas, with operations expected to begin in 2028. The new site will expand the ...
More than a dozen states sued the Trump administration Tuesday over its rollback of vaccine recommendations for children, calling the move an illegal threat to public health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results